South Korean medical aesthetics company Hugel hosted its Aesthetic Excellence Summit 2026 from Wednesday to Friday, bringing together 20 medical professionals from Europe, Asia, the Middle East and South America for hands-on training in cosmetic procedures.
Held twice a year under the Hugel Expert Leader's Forum, the summit aims to strengthen overseas practitioners' clinical skills and promote Korean aesthetic medicine.
On the first day, participants toured Hugel's manufacturing facilities to learn about its production and quality control processes. Interactive sessions demonstrated how botulinum toxin works, including the "narrow diffusion" concept associated with its Letybo product, while showcasing different stages of dermal filler production.
Botulinum toxin, more commonly known by brand names such as Botox, is a neurotoxin that temporarily blocks signals between nerves and muscles and is usually used in aesthetic treatments to soften wrinkles and fine lines. Letybo's "narrow diffusion" process helps concentrate its effects on the targeted area for more precise treatment.
The second day featured anatomy training and practical workshops at the Catholic Institute for Applied Anatomy. Dermatologists Lee Kyu-ho and Yoon Chang-il, alongside Wonkwang University dentistry professor Kim Soo-bin, provided instruction on anatomically guided injection techniques for botulinum toxin and hyaluronic acid fillers.
On the final day, plastic surgeon Seo Hyun-woo presented the latest aesthetic treatment trends and facial injection protocols, followed by a live demonstration.
Hadeel Qudah, a dermatologist from Jordan, said the program offered valuable insights into Hugel's manufacturing standards and practical techniques applicable to clinical practice.
"We will continue introducing international practitioners to the philosophy of K-aesthetics, evidence-based techniques and our commitment to quality," Shin Seung-jun, executive vice president of Hugel's Medical Business Division, said.
jyoungseon8@heraldcorp.com
